Dermatomyositis Completed Phase 2 / 3 Trials for Tacrolimus (DB00864)

Also known as: Dermatomyositides / Dermatopolymyositis, unspecified

IndicationStatusPhase
DBCOND0002234 (Dermatomyositis)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00504348Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant TacrolimusTreatment